This Is By Far My #1 Income Stock

No strings attached...

I am often asked what my favorite dividend stock is. So I want to share the one single stock that's by far my favorite right now. Unlike many dividend-paying companies... which rely on boring income through utilities, rent or oil... This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year. And it has a pipeline of other blockbuster drugs, which are expected to generate $35 billion in sales. It doesn't take a genius to know that healthcare is at the forefront of everyone's mind right now, including the folks on Wall Street. Last year, this company's stellar drug sales allowed it to pay shareholders $5.6 billion in dividends. That's cash you can claim a piece of. And today, I want to give you the name, the ticker symbol and my full analysis completely free – no strings attached. Click here to get it. Sincerely, Marc Lichtenfeld Chief Income Strategist, The Oxford Club P.S. When I say FREE, I mean it. There is no catch. You get my entire Ultimate Dividend Package... including my No. 1 dividend stock... free of charge. Here's how. This ad is sent on behalf of The Oxford Club. 105 W Monument St, Baltimore, Maryland 21201. If you would like to opt-out from receiving offers from The Oxford Club please click here.

Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.